RSS-Feed abonnieren
DOI: 10.1055/s-0037-1618364
Spondyloarthritiden und Früh diagnose
Zeitlicher Wandel und ZukunftSpondyloarthritides and early diagnosisWinds of change and futurePublikationsverlauf
Publikationsdatum:
27. Dezember 2017 (online)

Zusammenfassung
In den vergangenen 40 Jahren wurden infolge ätiopathogenetischer, klinischer und diagnostischer Fortschritte in wechselnder Folge Kriterien mit dem Ziel einer Frühdiagnose und Klassifizierung der Spondylitis ankylosans und Spondyloarthritiden entwickelt. Die Historie der für die Frühdiagnose relevanten Fortschritte und Grenzen wird aufgezeigt. Das Konzept einer Familie bzw. Gruppe von Erkrankungen, die durch überlappende familiäre, genetische und klinische Manifestationen miteinander verbunden sind, ist nicht überholt. Die Unterteilung der SpA in definierte nosologische Kategorien für die Diagnose und Frühdiagnose einzelner Patienten, die Patienteninformation, die individuelle Behandlung und die prognostische Beurteilung wird weiterhin benötigt. Infektionen, insbesondere mit Chlamydien, werden als auslö-sender Faktor und ätiologischer Beitrag zur Diagnose der Spondyloarthritis nicht ausreichend berücksichtigt. Die ASAS-Klassifikationskriterien für die axiale und periphere Spondyloarthritis sind für Studien wichtig, jedoch in der Praxis nicht unkritisch für die Frühdiagnose einsetzbar. Zukünftige Möglichkeiten zur Verbesserung der Frühdiagnose werden angesprochen.
Summary
Over the past 40 years criteria were developed in alternating sequence for early diagnosis and classification of ankylosing spondylitis and spondyloarthritis as a result of etiopathogenetic, clinical and diagnostic advances. The history is presented related to progress and limitations for early diagnosis. The concept of a family or group of diseases which are connected by overlapping familial, genetic, and clinical manifestations is not outdated. The subdivision of SpA in defined nosological categories is still required for diagnosis and early diagnosis of individual patients, patient information, individualized treatment, and prognostic evaluation. Infections, especially with Chlamydia, are not considered sufficiently as a causative factor and etiological contribution to the diagnosis of spondyloarthritis. The ASAS classification criteria for axial and peripheral spondylo -arthritis are important for studies, but should not be used uncritically in practice for early diagnosis. Future opportunities will be addressed how to improve early diagnosis.
-
Literatur
- 1 Blumberg B, Bunim JJ, Calkins E. et al ARA nomenclature and classification of arthritis and rheumatism (tentative). Arthritis Rheum 1964; 7: 93-97.
- 2 Guignard S, Gossec L, Dougados M. Diagnostic and classification criteria. In Weisman M. van der Heijde D, Reveille J. Hrsg. Ankylosing spondylitis and the spondyloarthropathies.. Philadelphia: Mosby Elsevier; 2006: 132-144.
- 3 Zeidler H, Calin A, Amor B. A historical perspective of the spondyloarthritis. Curr Opin Rheumatol 2011; 23: 327-333.
- 4 Moll JMH, Haslock I, Macrae IF. et al Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and Behcet’s syndrome. Medicine 1974; 53: 343-364.
- 5 Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum 1978; 21: 619-633.
- 6 François RJ, Eulderink F, Bywaters EG. Commented glossary for rheumatic spinal diseases, based on pathology. Ann Rheum Dis 1995; 54: 615-625.
- 7 Zeidler H, Mau R, Mau W. et al Evaluation of early diagnostic criteria including HLA-B27 for ankylosing spondylitis in a follow-up study. Z Rheumatol 1985; 44: 249-253.
- 8 Mau W, Zeidler H, Mau R. et al Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988; 15: 1109-1114.
- 9 Mau W, Zeidler H, Mau R. et al Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up. Z Rheumatol 1990; 49: 82-87.
- 10 Amor B, Dougados M, Mijiyawa M. Critères de classification des spondylarthropathies. Rev Rhum Mal Osteoartic 1990; 57: 85-89.
- 11 Dougados M, van der Linden S, Juhlin R. et al The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-1227.
- 12 Rudwaleit M, van der Heijde D, Khan MA. et al How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004; 63: 535-543.
- 13 Song IH, Rudwaleit M. Klassifikation und Diagnose der ankylosierenden Spondylitis. arthritis + rheuma 2008; 28: 328-332.
- 14 Poddubnyy D, Rudwaleit M, Haibel H. et al Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011; 70: 1369-1374.
- 15 Aydin SZ, Maksymowych WP, Bennett AN. et al Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 2012; 71: 56-60.
- 16 Poddubnyy D, Brandt H, Vahldiek J. et al The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann Rheum Dis 2012; 71: 1998-2001.
- 17 Rudwaleit M, van der Heijde D, Landewé R. et al The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2010; 70: 25-31.
- 18 Baraliakos X, Kiltz U, Heldmann F, Braun J. Modernes Konzept der axialen Spondyloarthritis. arthritis + rheuma 2013; 33: 71-76.
- 19 Zeidler Amor. The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis 2011; 70: 1-3.
- 20 van den Berg R, de Hooge M, van Gaalen F. et al Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 2013; 52: 1492-1499.
- 21 Zeidler H. Peripheral arthritis in patients classified as having nonradiographic axial spondyloarthritis in trials of anti-tumor necrosis factor agents: comment on the article by Dougados, et al. Arthritis Rheumatol 2014; 67: 1138-1139.
- 22 Tomero E, Mulero J, de Miguel E. et al Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. Rheumatology (Oxford) 2014; 53: 353-360.
- 23 Braun J, Baraliakos X, Kiltz U. et al Classification and Diagnosis of Axial Spondyloarthritis - What Is the Clinically Relevant Difference?. J Rheumatol 2015; 42: 31-38.
- 24 Kiltz U, Braun J. DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. Editorial. Z Rheumatol 2014; 73 (Suppl. 02) Suppl 20-22.
- 25 Kiltz U, Rudwaleit M, Sieper J. et al DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. 5 Erstdiagnose/Überweisungsstrategie. Z Rheumatol 2014; 73 (Suppl. 02) Suppl 44-48.
- 26 Kiltz U, Rudwaleit M, Sieper J. et al DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. 6 Diagnostik. Z Rheumatol 2014; 73 (Suppl. 02) Suppl 49-65.
- 27 Inman RD, Stone MA. Infection and spondyloarthritis. In Weisman M, van der Heijde D, Reveille J. eds. Ankylosing spondylitis and the spondyloarthropathies.. Philadelphia: Mosby Elsevier; 2006: 38-52.
- 28 Zeidler H, Hudson AP. New insights into Chlamydia and arthritis. Promise of a cure?. Ann Rheum Dis 2014; 73: 637-644.
- 29 Carter JD, Gerard HC, Espinoza LR. et al Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009; 60: 1311-1316.
- 30 Rihl M, Wagner AD, Bakhsh KA. et al Detection of chlamydial DNA in the inflamed sacroiliac joint of a patient with multiple infections. J Clin Rheumatol 2009; 15: 195-197.
- 31 Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 2004; 31: 1973-1980.
- 32 Carter JD, Espinoza LR, Inman RD. et al Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010; 62: 1298-1307.
- 33 Rihl M, Kuipers JG, Köhler L. et al Combination antibiotics for Chlamydia-induced arthritis: breakthrough to a cure?. Arthritis Rheum 2010; 62: 1203-1207.
- 34 Wollenhaupt J, Zeidler H. Klinik, Diagnostik und Therapie der Chlamydien-induzierten Arthritis. Akt Rheumatol 1997; 22: 176-182.
- 35 Berthelot JM, de la Cochetière MF, Potel G. et al Evidence supporting a role for dormant bacteria in the pathogenesis of spondylarthritis. Joint Bone Spine 2013; 80: 135-140.
- 36 Salehi-Abari I, Khazaeli S, Khak M. Early diagnosis of ankylosing spondylitis: an introduction to the newly designed Iran criteria for ankylosing spondylitis. Rheumatol Int 2013; 33: 1303-1308.
- 37 Braun A, Gnann H, Saracbasi E. et al Optimizing the identification of patients with axial spondyloarthritis in primary care - the case for a two-step strategy combining the most relevant clinical items with HLA B27. Rheumatology (Oxford) 2013; 52: 1418-1424.
- 38 Brandt H. Screening-Parameter zur Frühdiagnose der axialen Spondyloarthritis (SpA) - Überweisungsmuster und -indikationen. arthritis + rheuma 2008; 28: 333-334.
- 39 Baerlecken NT, Nothdorft S, Stummvoll GH, et al. Autoantibodies against CD74 in spondyloarthritis. Ann Rheum Dis 2014; 73: 1211-1214.
- 40 Baraliakos X, Baerlecken N, Witte T. et al High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Ann Rheum Dis 2014; 73: 1079-1082.
- 41 Zeidler H, Brandt J, Schnarr S. Undifferentiated spondyloarthritis. In Weisman MH, Reveille JD. van der Heijde D. Hrsg. Ankylosing Spondylitis and the Spondyloarthropathies.. Philadelphia: Mosby Elsevier; 2006: 75-93.